Seeking Alpha

Sanofi (SNY -0.6%) and Regeneron (REGN +7.8%) report that the European Medicines Agency's CHMP...

Sanofi (SNY -0.6%) and Regeneron (REGN +7.8%) report that the European Medicines Agency's CHMP has recommended granting marketing authorization for Zaltrap Injection for Intravenous Infusion in combination with FOLFIRI chemotherapy in adults with metastatic colorectal cancer. All that remains is for the European Commission to ratify the positive opinion from the CHMP to grant marketing authorization in all 27 E.U. member countries. A decision is expected in Q113.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|